The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

234

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

August 22, 2024

Study Completion Date

December 31, 2030

Conditions

Hand-foot Syndrome

Interventions

DRUG

Mecobalamin 5 MG Disintegrating Oral Tablet

Mecobalamin 0.5mg / time, 3 times / day,was taken continuously for 6 months

DRUG

placebo

placebo 0.5mg / time, 3 times / day,was taken continuously for 6 months

Trial Locations (1)

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER